Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?
Here to discuss the results of a study designed to test the feasibility of this therapeutic approach is neurologist Saud Sadiq. Dr Sadiq is Founder and Director of the International Multiple Sclerosis Management Practice and the Multiple Sclerosis Research Center of New York.
|Intrathecal Methotrexate for Patients With MS?|
Intrathecal Methotrexate for Patients With MS?